Manganic encephalopathy due to "ephedrone" abuse

Movement Disorders

Volumn 22, Issue 9, 2007, Pages 1337-1343

  Sanotsky, Yanush ^a   Lesyk, Roman ^b   Fedoryshyn, Lyudmyla ^a   Komnatska, Iryna ^c   Matviyenko, Yuriy ^b   Fahn, Stanley ^d  

^a Lviv Regional Clinical Hospital   (Ukraine)

^b DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^c Department of MRI   (Ukraine)

^d NewYork Presbyterian Hospital   (United States)

Author keywords

Drug addiction; Ephedronic encephalopathy; Manganese poisoning; Manganic encephalopathy; Parkinsonism

Indexed keywords

AMINE; LEVODOPA; METHCATHINONE; PHENYLPROPANONEAMINE; UNCLASSIFIED DRUG;

ADULT; APATHY; ARTICLE; BRADYKINESIA; BRAIN DISEASE; CATALYST; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG ABUSE; DYSARTHRIA; EUPHORIA; FEMALE; GAIT DISORDER; HUMAN; INTOXICATION; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SELF INJECTION;

ADULT; BASAL GANGLIA; BRAIN DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MANGANESE POISONING; MIDDLE AGED; PROPIOPHENONES; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS;

EID: 34548206713     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21378     Document Type: Article

References (33)

1. Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely, and Jones; 1817.
2. Couper J. On the effects of black oxide of manganese when inhaled into lungs. Br Ann Med Pharm 1837;1:41-42.
3. Edsall DL, Wilbur FP, Drinker CK. The occurrence, course and prevention of chronic manganese poisoning. J Ind Hyg 1919;1: 183-193.
4. Canavan MM, Cobb SS, Drinker CK. Chronic manganese poisoning. Arch Neurol Psychiat 1934;32:501-512.
5. Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974;30:59-64.
6. Sadek AH, Rauch R, Schulz PE. Parkinsonism due to manganism in a welder. Int J Toxicol 2003;22:393-401.
7. Herrero Hernandez E, Discalzi G, Dassi P, Jarre L, Pira E. Manganese intoxication: the cause of an inexplicable epileptic syndrome in a 3 year old child. Neurotoxicology 2003;24(4/5):633-639.
8. Mena I, Court J, Fuenzalida S, Papavasiliou PS, Cotzias GC. Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane. N Engl J Med 1970;282:5-10.
9. Fell JME, Reynolds AP, Meadow, et al. Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 1996;347: 1218-1221.
10. Masumoto K, Suita S, Taguchi T, et al. Manganese intoxication during intermittent parenteral nutrition: report of two cases. J Parenter Enteral Nutr 2001;25(2):95-99.
11. Ferraz HB, Bertolucci PHF, Pereira JS, et al. Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication. Neurology 1988;38:550-553.
12. Hauser RA, Zesiewicz TA, Rosemurgy AS, Martinez C, Olanow CW. Manganese intoxication and chronic liver failure. Ann Neurol 1994;36:871-875.
13. Levin OS, Fedorova NV, Amosova NA, Shtok VN. Ephedronic parkinsonism. Nevrologicheskyy Zhurnal 2000;2:8-15.
14. Levin OS. "Ephedron" encephalopathy. Zh Nevrol Psikhiatr Im S S Korsakova 2005;105(7):12-20.
15. Mironenko TV. Manganese encephalopathy, neurologic aspects. Ukrayinskyy Medychnyy Almanakh 2004;7(4) (Suppl):86-89.
16. Belhadj-Tahar H, Sadeg N. Methcathinone: a new postindustrial drug. Forensic Sci Int 2005;153(1):99-101.
17. Ladurner G, Kalvach P, Moessler H; Cerebrolysin Study Group. Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial. J Neural Transm 2005;112: 415-428.
18. Lucchini R, Albini E, Placidi D, et al. Brain magnetic resonance imaging and manganese exposure. Neurotoxicology 2000;21:769-775.
19. Ballard PA, Tetrud JW, Langston JW: Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 1985;35:949-956.
20. Yamada M, Ohno S, Okayasu I, et al. Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neupathol 1986;70:273-278.
21. Mella H. The experimental production of basal ganglia symptomatology in Macacus rhesus. Arch Neurol Psychiat 1924;11:405-417.
22. Olanow CW, Good PF, Shinotoh H, et al. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study. Neurology 1996;46:492-498.
23. Kim E, Kim Y, Cheong HK, et al. Pallidal index on MRI as a target organ dose of manganese: structural equation model analysis. Neurotoxicology 2005;26:351-359.
24. Newland M, Cox C, Hamada R, et al. The clearance of manganese chloride in the primate. Fundam Appl Toxicol 1987;9:314-328.
25. Wolters EC, Huang CC, Clark C, et al. Positron emission tomography in manganese intoxication. Ann Neurol 1989;26:647-651.
26. Huang CC, Chu NS, Lu CS, Calne DB. Cock gait in manganese intoxication. Mov Disord 1997;12:807-808.
27. Huang CC, Chu NS, Lu CS, et al. Chronic manganese intoxication. Arch Neurol 1989;46:1104-1106.
28. Huang CC, Lu CS, Chu NS, et al. Progression after chronic manganese exposure. Neurology 1993;43:1479-1483.
29. Rafael P. Diagnosis and treatment of manganese intoxication: report of a case. Arch Ind Health 1957;16:64-66.
30. Mena I, Court J, Fuenzalida S, Papavasiliou PS, Cotzias GC. Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane. N Engl J Med 1970;282(1):5-10.
31. Rosenstock HA, Simons DG, Meyer JS. Chronic manganism: neurological and laboratory studies during treatment with levodopa. JAMA 1971;217:1354-1358.
32. Lu CS, Huang CC, Chu NS, Calne DB. Levodopa failure in chronic manganism. Neurology 1994;44:1600-1602.
33. Mena I. Manganese poisoning. In: Vinkeen PJ, Bruyn GW, editors. Handbook of clinical neurology, Vol. 36. Amsterdam: Elsevier/North-Holland; 1979. P 217-237.